Activity ID
13704Expires
December 31, 2025Format Type
LiveCME Credit
0.5Fee
$0CME Provider: AdventHealth Orlando
Description of CME Course
Education that provides invaluable insights into the evolving landscape of lung cancer therapeutics, offering a comprehensive overview of current practices and future directions in treatment. Lectures may include in-depth discussions exploring the latest advancements in lung cancer treatments and may involve biomarker testing, immunotherapy, targeted therapy, surgical and non-surgical options.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Allergy and Immunology
Anesthesiology
Colon and Rectal Surgery
Family Medicine
Medical Genetics and Genomics
Nuclear Medicine
Ophthalmology
Physical Medicine and Rehabilitation
Plastic Surgery
Preventive Medicine
Psychiatry and Neurology
Radiology
Urology
Commercial Support?
NoNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
1. Describe emerging scientific and clinical data, novel treatment strategies and other advances in the program topic to optimize management principles.
2. Interpret evidence-based guidelines alongside clinical research for program topic to improve delivery of care.
3. Discuss the importance of a multidisciplinary approach to elevate coordinated care for cancer patients.
Competencies
Medical Knowledge, Patient Care & Procedural Skills, Practice-based Learning & Improvement
CME Credit Type
AMA PRA Category 1 Credit
Practice Setting
Outpatient
